Subscribe

Futures & Options World Copying and distributing are prohibited without permission of the publisher
Email a friend
  • To include more than one recipient, please seperate each email address with a semi-colon ';'


Newedge Japan chief steps down

01 February 2011

Read more: Japan CME FOW Asia Japan

(we have pic)

Julien Le Noble is stepping down as managing director and head of Newedge Japan.

He will be replaced by Yoshio Kuno, head of CME Group’s Tokyo office.

Nicholas Scarf becomes head of the derivatives broker’s Singapore office, replacing Jerome Burban, who has left Newedge.

FOi understands that Le Noble will leave his position soon. It is unclear whether he will remain with the firm in a new role.

After several years in Chicago and London, Le Noble moved to Asia in 2002, to run the Newedge Singapore office.

He took the helm in Japan in 2006, leading the team through the 2008 merger and integration of Calyon Financial and Fimat, owned by Société Générale.

Le Noble has overseen Newedge’s expansion to become Japan’s largest derivatives brokerage. In 2007 it acquired Hinawari, but Newedge also made a series of initiatives in technology drive and advanced risk management solutions.

Le Noble is also active in the Futures Industry Association of Japan. He has advocated modernising Japan’s clearing infrastructure and addressing the fragmentation of its exchanges.

Kuno joins Newedge, reporting to Asia Pacific head Laurent Cunin, after 12 years at CME Group. Before that, he was senior vice-president and general manager of BA Futures.

Scarf is moving to Newedge Singapore, having headed the firm’s Sydney office. He joined from MF Global in 2009, and was previously a director at the proprietary trading firm TransMarket Group.

Burban leaves Newedge after most recently being managing director, Singapore.

He joined Fimat in 2004 as head of sales in Mumbai.


Have your say
  • All comments are subject to editorial review.
    All fields are compulsory.

Poll

What concerns you most about the upcoming regulation changes?

Opportunity for regulatory arbitrage
12%
Impact on revenues
36%
Unnecessary complexity
10%
Workability of central clearing for OTC derivatives
11%
Workability of forcing complex derivatives onto exchanges
30%